BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 26096658)

  • 21. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
    Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
    Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.
    Wang L; Wang J; Li Z; Liu Y; Jiang M; Li Y; Cao D; Zhao M; Wang F; Luo F
    Tumour Biol; 2016 Jun; 37(6):7213-27. PubMed ID: 26666817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
    Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
    PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
    Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
    BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.
    Xue L; Yu X; Jiang X; Deng X; Mao L; Guo L; Fan J; Fan Q; Wang L; Lu SH
    Oncotarget; 2017 Mar; 8(12):19274-19284. PubMed ID: 27974706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
    Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
    J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells.
    Hyun KH; Yoon CH; Kim RK; Lim EJ; An S; Park MJ; Hyun JW; Suh Y; Kim MJ; Lee SJ
    Toxicol Appl Pharmacol; 2011 Jul; 254(1):32-40. PubMed ID: 21514314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.
    Sun FF; Hu YH; Xiong LP; Tu XY; Zhao JH; Chen SS; Song J; Ye XQ
    Int J Clin Exp Pathol; 2015; 8(6):6287-300. PubMed ID: 26261505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
    Zhang G; Ma L; Xie YK; Miao XB; Jin C
    Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
    Rybak AP; He L; Kapoor A; Cutz JC; Tang D
    Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
    Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
    Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.
    Wang H; Yang M; Lin L; Ren H; Lin C; Lin S; Shen G; Ji B; Meng C
    Cell Oncol (Dordr); 2016 Feb; 39(1):35-45. PubMed ID: 26650484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
    Wang L; Guo H; Lin C; Yang L; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
    Manrique I; Nguewa P; Bleau AM; Nistal-Villan E; Lopez I; Villalba M; Gil-Bazo I; Calvo A
    Cancer Lett; 2015 Jan; 356(2 Pt B):899-909. PubMed ID: 25449776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.